How Germany Has Transposed the New EU Pharmaceutical Legislation
This article was originally published in SRA
Claudia Hey reports on the 14th amendment to the German Medicine Act.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.